 Monika Headrick
Concepts (536)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 42 | 2023 | 1203 | 4.530 |
Why?
| | Erythrocytes | 28 | 2024 | 749 | 4.190 |
Why?
| | Blood Proteins | 11 | 2020 | 239 | 3.480 |
Why?
| | Proteome | 20 | 2022 | 520 | 3.110 |
Why?
| | Blood Preservation | 16 | 2024 | 346 | 3.030 |
Why?
| | Erythrocyte Transfusion | 9 | 2023 | 225 | 2.500 |
Why?
| | Hemolysis | 12 | 2024 | 242 | 2.180 |
Why?
| | Fibrinolysis | 7 | 2022 | 164 | 1.850 |
Why?
| | Extracellular Matrix Proteins | 5 | 2021 | 156 | 1.640 |
Why?
| | Extracellular Matrix | 8 | 2023 | 566 | 1.470 |
Why?
| | Mass Spectrometry | 14 | 2019 | 728 | 1.370 |
Why?
| | Chromatography, Liquid | 7 | 2017 | 453 | 1.220 |
Why?
| | Blood Coagulation Disorders | 5 | 2023 | 198 | 1.200 |
Why?
| | Mesentery | 3 | 2014 | 44 | 1.180 |
Why?
| | Anemia, Sickle Cell | 4 | 2023 | 322 | 1.070 |
Why?
| | beta-Thalassemia | 4 | 2023 | 40 | 1.030 |
Why?
| | Wounds and Injuries | 6 | 2022 | 977 | 1.030 |
Why?
| | Lymph | 3 | 2018 | 31 | 0.980 |
Why?
| | Tissue Plasminogen Activator | 6 | 2023 | 248 | 0.980 |
Why?
| | Tandem Mass Spectrometry | 7 | 2016 | 575 | 0.960 |
Why?
| | Plasma | 4 | 2017 | 224 | 0.940 |
Why?
| | Blood Coagulation | 6 | 2023 | 274 | 0.890 |
Why?
| | Tissue Scaffolds | 2 | 2019 | 221 | 0.870 |
Why?
| | Plateletpheresis | 2 | 2015 | 28 | 0.850 |
Why?
| | Survival of Motor Neuron 1 Protein | 2 | 2016 | 11 | 0.840 |
Why?
| | Blood Platelets | 4 | 2015 | 381 | 0.830 |
Why?
| | Reticulocytes | 1 | 2023 | 17 | 0.800 |
Why?
| | Lipopolysaccharides | 10 | 2022 | 863 | 0.800 |
Why?
| | Isoantibodies | 1 | 2023 | 57 | 0.780 |
Why?
| | Extracellular Vesicles | 5 | 2023 | 175 | 0.770 |
Why?
| | Blood Donors | 5 | 2024 | 145 | 0.720 |
Why?
| | Arginine | 1 | 2022 | 265 | 0.670 |
Why?
| | Metabolome | 4 | 2021 | 391 | 0.660 |
Why?
| | Oxidative Stress | 10 | 2022 | 1368 | 0.660 |
Why?
| | Shock, Hemorrhagic | 5 | 2023 | 200 | 0.620 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 2017 | 332 | 0.610 |
Why?
| | Humans | 81 | 2024 | 147293 | 0.610 |
Why?
| | Acellular Dermis | 1 | 2019 | 11 | 0.600 |
Why?
| | Animals | 38 | 2023 | 38410 | 0.600 |
Why?
| | Sex Characteristics | 3 | 2015 | 799 | 0.580 |
Why?
| | Lipid Metabolism | 2 | 2017 | 538 | 0.570 |
Why?
| | Thrombelastography | 7 | 2023 | 192 | 0.550 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 387 | 0.550 |
Why?
| | Coronavirus Infections | 2 | 2020 | 378 | 0.550 |
Why?
| | Hypoxia | 7 | 2023 | 1208 | 0.540 |
Why?
| | Metabolomics | 7 | 2024 | 736 | 0.540 |
Why?
| | Complement System Proteins | 2 | 2021 | 320 | 0.530 |
Why?
| | Tissue Engineering | 3 | 2019 | 439 | 0.530 |
Why?
| | Hemoglobins | 4 | 2022 | 386 | 0.530 |
Why?
| | Hydroxylamine | 1 | 2017 | 7 | 0.530 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2017 | 85 | 0.520 |
Why?
| | Hydrogels | 4 | 2023 | 706 | 0.500 |
Why?
| | Mice | 19 | 2023 | 18491 | 0.490 |
Why?
| | Interleukin-6 | 2 | 2020 | 784 | 0.480 |
Why?
| | Mycophenolic Acid | 1 | 2017 | 119 | 0.480 |
Why?
| | Nucleotides | 1 | 2017 | 129 | 0.480 |
Why?
| | Coiled Bodies | 1 | 2016 | 8 | 0.470 |
Why?
| | Campylobacter jejuni | 3 | 2011 | 16 | 0.470 |
Why?
| | Pandemics | 3 | 2023 | 1720 | 0.460 |
Why?
| | Microtubule-Associated Proteins | 2 | 2021 | 197 | 0.450 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.450 |
Why?
| | Myocardium | 3 | 2022 | 947 | 0.440 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2020 | 34 | 0.430 |
Why?
| | Extinction, Biological | 1 | 2015 | 34 | 0.430 |
Why?
| | Oxidation-Reduction | 7 | 2021 | 1077 | 0.410 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2016 | 199 | 0.410 |
Why?
| | Neutrophils | 4 | 2022 | 1135 | 0.390 |
Why?
| | Lymph Nodes | 2 | 2018 | 514 | 0.380 |
Why?
| | Proteolysis | 2 | 2017 | 173 | 0.380 |
Why?
| | Paxillin | 1 | 2022 | 11 | 0.380 |
Why?
| | Erythrocyte Deformability | 1 | 2022 | 23 | 0.370 |
Why?
| | Thrombophilia | 1 | 2023 | 89 | 0.370 |
Why?
| | Collagen | 1 | 2015 | 460 | 0.370 |
Why?
| | Repressor Proteins | 1 | 2016 | 429 | 0.360 |
Why?
| | Valosin Containing Protein | 1 | 2022 | 8 | 0.360 |
Why?
| | Superoxides | 2 | 2022 | 199 | 0.360 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2012 | 70 | 0.360 |
Why?
| | Immunosuppressive Agents | 1 | 2017 | 840 | 0.360 |
Why?
| | O Antigens | 3 | 2006 | 8 | 0.350 |
Why?
| | Cytoplasmic Dyneins | 1 | 2021 | 8 | 0.350 |
Why?
| | Cell Proliferation | 6 | 2022 | 2529 | 0.350 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2022 | 33 | 0.340 |
Why?
| | Oxygen | 3 | 2022 | 998 | 0.340 |
Why?
| | Nervous System Malformations | 1 | 2022 | 46 | 0.340 |
Why?
| | Carnitine | 1 | 2022 | 91 | 0.340 |
Why?
| | Glycolysis | 4 | 2022 | 341 | 0.340 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 6 | 2021 | 849 | 0.340 |
Why?
| | Nanoparticles | 2 | 2022 | 524 | 0.340 |
Why?
| | Plesiomonas | 3 | 2006 | 3 | 0.340 |
Why?
| | Intestinal Mucosa | 1 | 2017 | 676 | 0.330 |
Why?
| | Gangliosides | 1 | 2011 | 23 | 0.330 |
Why?
| | Biomarkers | 8 | 2022 | 4351 | 0.330 |
Why?
| | Endosomes | 1 | 2021 | 140 | 0.320 |
Why?
| | Male | 28 | 2023 | 73950 | 0.320 |
Why?
| | B7-H1 Antigen | 1 | 2022 | 246 | 0.310 |
Why?
| | Female | 27 | 2023 | 80076 | 0.300 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2019 | 49 | 0.290 |
Why?
| | Molecular Sequence Data | 9 | 2015 | 2886 | 0.290 |
Why?
| | Proteins | 2 | 2023 | 1024 | 0.290 |
Why?
| | Glioblastoma | 1 | 2022 | 354 | 0.290 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 1 | 2019 | 54 | 0.290 |
Why?
| | Androgen Antagonists | 1 | 2019 | 91 | 0.280 |
Why?
| | Resuscitation | 3 | 2017 | 318 | 0.280 |
Why?
| | Biological Products | 1 | 2022 | 258 | 0.280 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 98 | 0.280 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 430 | 0.280 |
Why?
| | Thrombosis | 1 | 2022 | 401 | 0.280 |
Why?
| | Breast Neoplasms | 3 | 2022 | 2420 | 0.280 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1224 | 0.280 |
Why?
| | Protein Processing, Post-Translational | 3 | 2019 | 480 | 0.270 |
Why?
| | Cells, Cultured | 7 | 2021 | 4169 | 0.270 |
Why?
| | Androgens | 1 | 2019 | 181 | 0.270 |
Why?
| | Lymphokines | 1 | 2017 | 128 | 0.260 |
Why?
| | Leukocyte Reduction Procedures | 2 | 2018 | 29 | 0.250 |
Why?
| | Hematopoietic Stem Cells | 1 | 2021 | 435 | 0.250 |
Why?
| | Energy Metabolism | 3 | 2022 | 936 | 0.250 |
Why?
| | Asparagine | 2 | 2018 | 35 | 0.250 |
Why?
| | Ketones | 1 | 2017 | 51 | 0.250 |
Why?
| | Brain Injuries, Traumatic | 1 | 2023 | 462 | 0.250 |
Why?
| | alpha 1-Antitrypsin | 2 | 2022 | 104 | 0.250 |
Why?
| | Chondrogenesis | 2 | 2020 | 88 | 0.250 |
Why?
| | Apocrine Glands | 1 | 2016 | 5 | 0.240 |
Why?
| | Adult | 18 | 2023 | 41405 | 0.240 |
Why?
| | Aldehydes | 1 | 2017 | 140 | 0.240 |
Why?
| | Xanthine Dehydrogenase | 1 | 2016 | 24 | 0.240 |
Why?
| | Neutrophil Activation | 2 | 2018 | 84 | 0.240 |
Why?
| | Rats | 7 | 2023 | 5613 | 0.240 |
Why?
| | Inflammation | 7 | 2023 | 2920 | 0.240 |
Why?
| | Transcriptome | 3 | 2022 | 1059 | 0.230 |
Why?
| | Cell Line, Tumor | 7 | 2022 | 3565 | 0.230 |
Why?
| | Glycolipids | 1 | 2016 | 53 | 0.230 |
Why?
| | Milk | 1 | 2016 | 119 | 0.230 |
Why?
| | Molecular Chaperones | 1 | 2017 | 199 | 0.230 |
Why?
| | Time Factors | 6 | 2018 | 7173 | 0.230 |
Why?
| | Injury Severity Score | 2 | 2018 | 602 | 0.230 |
Why?
| | Middle Aged | 14 | 2023 | 36821 | 0.230 |
Why?
| | Lung | 3 | 2015 | 4141 | 0.220 |
Why?
| | Hemorrhage | 4 | 2023 | 832 | 0.220 |
Why?
| | Multiple Organ Failure | 2 | 2022 | 122 | 0.220 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2022 | 673 | 0.220 |
Why?
| | Electrophoresis, Capillary | 3 | 2008 | 20 | 0.220 |
Why?
| | Magnetic Resonance Spectroscopy | 4 | 2017 | 627 | 0.210 |
Why?
| | Bacteria | 2 | 2022 | 769 | 0.210 |
Why?
| | Protein Conformation | 1 | 2017 | 943 | 0.210 |
Why?
| | Glycoproteins | 1 | 2016 | 358 | 0.210 |
Why?
| | Cell Membrane | 2 | 2016 | 711 | 0.210 |
Why?
| | Amino Acid Sequence | 4 | 2015 | 2134 | 0.210 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2015 | 130 | 0.200 |
Why?
| | Blood Group Antigens | 1 | 2023 | 15 | 0.200 |
Why?
| | Ubiquitination | 2 | 2016 | 119 | 0.200 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 15 | 0.200 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2019 | 889 | 0.200 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2022 | 269 | 0.200 |
Why?
| | Interferons | 2 | 2022 | 186 | 0.200 |
Why?
| | Epitopes | 3 | 2008 | 475 | 0.200 |
Why?
| | Birth Injuries | 1 | 2023 | 18 | 0.190 |
Why?
| | Swine | 3 | 2023 | 828 | 0.190 |
Why?
| | Reactive Oxygen Species | 5 | 2022 | 616 | 0.190 |
Why?
| | Hypocalcemia | 1 | 2023 | 40 | 0.190 |
Why?
| | Haemophilus influenzae | 2 | 2008 | 68 | 0.190 |
Why?
| | Glucose | 3 | 2018 | 1051 | 0.190 |
Why?
| | Acute-Phase Proteins | 2 | 2014 | 66 | 0.190 |
Why?
| | Brain Neoplasms | 1 | 2022 | 1338 | 0.190 |
Why?
| | Solubility | 2 | 2017 | 240 | 0.190 |
Why?
| | DNA Modification Methylases | 1 | 2022 | 19 | 0.190 |
Why?
| | Sphingosine | 1 | 2023 | 47 | 0.190 |
Why?
| | Proteasome Endopeptidase Complex | 3 | 2022 | 156 | 0.190 |
Why?
| | Carbohydrate Sequence | 7 | 2008 | 29 | 0.190 |
Why?
| | Serpins | 1 | 2022 | 28 | 0.190 |
Why?
| | Arginase | 1 | 2022 | 26 | 0.190 |
Why?
| | Pelvic Organ Prolapse | 1 | 2023 | 62 | 0.180 |
Why?
| | Platelet Transfusion | 1 | 2023 | 77 | 0.180 |
Why?
| | Lysophospholipids | 1 | 2023 | 80 | 0.180 |
Why?
| | Rejuvenation | 2 | 2021 | 18 | 0.180 |
Why?
| | Protein Transport | 2 | 2021 | 442 | 0.180 |
Why?
| | Citrulline | 1 | 2022 | 45 | 0.180 |
Why?
| | Erythroblasts | 1 | 2022 | 18 | 0.180 |
Why?
| | Blood Banks | 2 | 2021 | 50 | 0.180 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2022 | 70 | 0.180 |
Why?
| | beta-Globins | 1 | 2022 | 8 | 0.180 |
Why?
| | Fibrinolysin | 1 | 2022 | 19 | 0.170 |
Why?
| | Isoaspartic Acid | 1 | 2021 | 3 | 0.170 |
Why?
| | Protein D-Aspartate-L-Isoaspartate Methyltransferase | 1 | 2021 | 5 | 0.170 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 1 | 2021 | 23 | 0.170 |
Why?
| | Blood | 1 | 2022 | 107 | 0.170 |
Why?
| | Signal Transduction | 6 | 2022 | 5272 | 0.170 |
Why?
| | Case-Control Studies | 5 | 2022 | 3660 | 0.170 |
Why?
| | Methods | 2 | 2018 | 68 | 0.170 |
Why?
| | Macrophages | 4 | 2023 | 1529 | 0.170 |
Why?
| | Receptors, Glucocorticoid | 1 | 2022 | 132 | 0.160 |
Why?
| | Cell Cycle Proteins | 3 | 2022 | 633 | 0.160 |
Why?
| | Erythrocyte Membrane | 1 | 2021 | 55 | 0.160 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2015 | 415 | 0.160 |
Why?
| | Seroconversion | 1 | 2021 | 48 | 0.160 |
Why?
| | Endothelial Cells | 3 | 2023 | 886 | 0.160 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 35 | 0.160 |
Why?
| | Virulence Factors | 1 | 2022 | 175 | 0.160 |
Why?
| | Betacoronavirus | 2 | 2020 | 288 | 0.160 |
Why?
| | Hypertension, Pulmonary | 2 | 2022 | 1977 | 0.160 |
Why?
| | Saccharomyces cerevisiae | 2 | 2015 | 584 | 0.160 |
Why?
| | Thrombin | 3 | 2023 | 174 | 0.160 |
Why?
| | Databases, Genetic | 1 | 2021 | 240 | 0.160 |
Why?
| | Membrane Lipids | 1 | 2020 | 82 | 0.150 |
Why?
| | Lipid A | 2 | 2008 | 27 | 0.150 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 300 | 0.150 |
Why?
| | Cell Line | 5 | 2018 | 2832 | 0.150 |
Why?
| | Antibodies, Bacterial | 2 | 2008 | 148 | 0.150 |
Why?
| | Protein Stability | 2 | 2017 | 176 | 0.150 |
Why?
| | Spermatogenesis | 1 | 2020 | 91 | 0.150 |
Why?
| | Nitric Oxide | 2 | 2022 | 892 | 0.150 |
Why?
| | Parabiosis | 1 | 2019 | 11 | 0.150 |
Why?
| | Aging | 3 | 2021 | 1992 | 0.150 |
Why?
| | Dyneins | 1 | 2019 | 34 | 0.150 |
Why?
| | Altitude | 1 | 2023 | 470 | 0.150 |
Why?
| | Adenosine Triphosphatases | 2 | 2022 | 159 | 0.140 |
Why?
| | Semen Analysis | 2 | 2020 | 15 | 0.140 |
Why?
| | Oligosaccharides | 3 | 2006 | 61 | 0.140 |
Why?
| | Metabolic Networks and Pathways | 3 | 2022 | 175 | 0.140 |
Why?
| | Fertility | 1 | 2020 | 175 | 0.140 |
Why?
| | Aspartic Acid | 1 | 2018 | 88 | 0.140 |
Why?
| | Proteus penneri | 1 | 2008 | 1 | 0.140 |
Why?
| | Infertility, Male | 2 | 2020 | 82 | 0.140 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 6041 | 0.140 |
Why?
| | Basophils | 1 | 2018 | 52 | 0.130 |
Why?
| | Sodium Chloride | 2 | 2015 | 138 | 0.130 |
Why?
| | Anti-Allergic Agents | 1 | 2018 | 41 | 0.130 |
Why?
| | Omalizumab | 1 | 2018 | 44 | 0.130 |
Why?
| | Spermatozoa | 2 | 2020 | 109 | 0.130 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.130 |
Why?
| | Urticaria | 1 | 2018 | 38 | 0.130 |
Why?
| | Acetylation | 4 | 2019 | 262 | 0.130 |
Why?
| | Protons | 2 | 2007 | 96 | 0.130 |
Why?
| | Mice, Knockout | 2 | 2023 | 3153 | 0.130 |
Why?
| | Myocytes, Cardiac | 1 | 2022 | 547 | 0.130 |
Why?
| | Mitochondria | 2 | 2022 | 1000 | 0.130 |
Why?
| | Trastuzumab | 2 | 2022 | 119 | 0.130 |
Why?
| | Blood Transfusion | 3 | 2022 | 412 | 0.130 |
Why?
| | Microtubules | 1 | 2019 | 267 | 0.130 |
Why?
| | Fibrinolytic Agents | 2 | 2022 | 303 | 0.120 |
Why?
| | Basigin | 1 | 2017 | 24 | 0.120 |
Why?
| | Immune Sera | 2 | 2004 | 77 | 0.120 |
Why?
| | Chromatography, Affinity | 1 | 2017 | 82 | 0.120 |
Why?
| | Freeze Drying | 1 | 2017 | 81 | 0.120 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2018 | 536 | 0.120 |
Why?
| | Apoptosis | 3 | 2022 | 2454 | 0.120 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 7 | 0.120 |
Why?
| | DNA | 2 | 2022 | 1444 | 0.120 |
Why?
| | Preoperative Period | 1 | 2017 | 150 | 0.120 |
Why?
| | Mammals | 3 | 2022 | 286 | 0.120 |
Why?
| | Purines | 1 | 2017 | 188 | 0.120 |
Why?
| | Healthy Volunteers | 1 | 2017 | 219 | 0.120 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 43 | 0.120 |
Why?
| | Isotope Labeling | 1 | 2017 | 82 | 0.120 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 106 | 0.120 |
Why?
| | Pancreas | 1 | 2018 | 345 | 0.120 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1794 | 0.120 |
Why?
| | Fibroblasts | 1 | 2021 | 1039 | 0.120 |
Why?
| | Epithelial Cells | 2 | 2016 | 1141 | 0.110 |
Why?
| | Receptor, PAR-2 | 1 | 2015 | 6 | 0.110 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2015 | 25 | 0.110 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 154 | 0.110 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2016 | 30 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2542 | 0.110 |
Why?
| | Bison | 1 | 2015 | 4 | 0.110 |
Why?
| | Plasminogen | 1 | 2015 | 27 | 0.110 |
Why?
| | Workflow | 1 | 2017 | 183 | 0.110 |
Why?
| | Chemical Fractionation | 1 | 2015 | 29 | 0.110 |
Why?
| | Gelsolin | 1 | 2014 | 11 | 0.110 |
Why?
| | Hafnia alvei | 1 | 2004 | 1 | 0.110 |
Why?
| | Kallikreins | 1 | 2014 | 26 | 0.110 |
Why?
| | Microcirculation | 1 | 2015 | 142 | 0.110 |
Why?
| | Glycosylation | 1 | 2015 | 176 | 0.110 |
Why?
| | Glutamine | 1 | 2015 | 110 | 0.110 |
Why?
| | Serine Proteases | 1 | 2014 | 26 | 0.110 |
Why?
| | Myocardial Infarction | 1 | 2022 | 1213 | 0.110 |
Why?
| | Rats, Inbred F344 | 1 | 2015 | 269 | 0.100 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2007 | 176 | 0.100 |
Why?
| | Aquaporin 4 | 1 | 2015 | 102 | 0.100 |
Why?
| | Blood Component Transfusion | 1 | 2015 | 104 | 0.100 |
Why?
| | Complex Mixtures | 1 | 2014 | 11 | 0.100 |
Why?
| | Peptide Hydrolases | 1 | 2014 | 105 | 0.100 |
Why?
| | Bacterial Proteins | 4 | 2022 | 976 | 0.100 |
Why?
| | Organ Size | 1 | 2015 | 465 | 0.100 |
Why?
| | Skull | 1 | 2015 | 164 | 0.100 |
Why?
| | Blotting, Western | 2 | 2011 | 1186 | 0.100 |
Why?
| | Glycoconjugates | 1 | 2003 | 7 | 0.100 |
Why?
| | Tetanus Toxoid | 1 | 2003 | 34 | 0.100 |
Why?
| | Thromboplastin | 1 | 2023 | 67 | 0.100 |
Why?
| | Homeostasis | 2 | 2022 | 651 | 0.100 |
Why?
| | Cluster Analysis | 1 | 2014 | 502 | 0.100 |
Why?
| | Neural Stem Cells | 1 | 2015 | 168 | 0.100 |
Why?
| | Stem Cell Niche | 1 | 2013 | 58 | 0.100 |
Why?
| | Muscle, Skeletal | 2 | 2023 | 1798 | 0.100 |
Why?
| | Neuromyelitis Optica | 1 | 2015 | 141 | 0.090 |
Why?
| | Survival of Motor Neuron 2 Protein | 1 | 2012 | 8 | 0.090 |
Why?
| | High-Throughput Screening Assays | 1 | 2015 | 178 | 0.090 |
Why?
| | Prognosis | 2 | 2022 | 4383 | 0.090 |
Why?
| | Cumulus Cells | 1 | 2012 | 7 | 0.090 |
Why?
| | Pyruvates | 1 | 2022 | 23 | 0.090 |
Why?
| | Inosine | 1 | 2022 | 14 | 0.090 |
Why?
| | Ubiquitin-Specific Peptidase 7 | 1 | 2022 | 4 | 0.090 |
Why?
| | Spinal Muscular Atrophies of Childhood | 1 | 2012 | 20 | 0.090 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2022 | 25 | 0.090 |
Why?
| | Leukocyte Count | 1 | 2013 | 319 | 0.090 |
Why?
| | Central Nervous System | 1 | 2015 | 282 | 0.090 |
Why?
| | Endotoxins | 1 | 2003 | 217 | 0.090 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 536 | 0.090 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2017 | 194 | 0.090 |
Why?
| | Pilot Projects | 1 | 2018 | 1912 | 0.090 |
Why?
| | Lymphoid Tissue | 1 | 2022 | 81 | 0.090 |
Why?
| | Maternal Age | 1 | 2012 | 129 | 0.090 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2022 | 7 | 0.090 |
Why?
| | Catalase | 1 | 2022 | 134 | 0.090 |
Why?
| | Acute Lung Injury | 2 | 2015 | 312 | 0.090 |
Why?
| | Ubiquitin | 1 | 2022 | 84 | 0.090 |
Why?
| | Quality Control | 1 | 2022 | 161 | 0.090 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 334 | 0.090 |
Why?
| | Phosphates | 1 | 2022 | 177 | 0.090 |
Why?
| | beta 2-Microglobulin | 1 | 2011 | 48 | 0.090 |
Why?
| | Oxygen Consumption | 1 | 2014 | 721 | 0.090 |
Why?
| | Datasets as Topic | 2 | 2022 | 121 | 0.080 |
Why?
| | Leukocytes | 1 | 2013 | 301 | 0.080 |
Why?
| | Galactosyltransferases | 1 | 2011 | 12 | 0.080 |
Why?
| | Sialyltransferases | 1 | 2011 | 13 | 0.080 |
Why?
| | Transfusion Reaction | 1 | 2011 | 61 | 0.080 |
Why?
| | RNA-Binding Proteins | 1 | 2015 | 451 | 0.080 |
Why?
| | Transglutaminases | 1 | 2022 | 159 | 0.080 |
Why?
| | Young Adult | 4 | 2021 | 14437 | 0.080 |
Why?
| | HeLa Cells | 1 | 2012 | 633 | 0.080 |
Why?
| | Histones | 2 | 2022 | 672 | 0.080 |
Why?
| | Linoleic Acid | 1 | 2021 | 44 | 0.080 |
Why?
| | STAT3 Transcription Factor | 1 | 2022 | 215 | 0.080 |
Why?
| | Mice, SCID | 1 | 2021 | 369 | 0.080 |
Why?
| | Adenosine | 1 | 2022 | 255 | 0.080 |
Why?
| | Cell Self Renewal | 1 | 2021 | 52 | 0.080 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2006 | 143 | 0.080 |
Why?
| | Cardiac Surgical Procedures | 1 | 2017 | 616 | 0.080 |
Why?
| | Immunoglobulin G | 1 | 2015 | 901 | 0.080 |
Why?
| | Rabbits | 3 | 2014 | 654 | 0.080 |
Why?
| | Disease Models, Animal | 4 | 2023 | 4604 | 0.080 |
Why?
| | Substrate Specificity | 1 | 2011 | 387 | 0.080 |
Why?
| | HEK293 Cells | 1 | 2012 | 745 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 915 | 0.080 |
Why?
| | Astrocytes | 1 | 2022 | 230 | 0.080 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 616 | 0.080 |
Why?
| | Phenylthiohydantoin | 1 | 2019 | 44 | 0.070 |
Why?
| | Bordetella pertussis | 1 | 2009 | 5 | 0.070 |
Why?
| | Glucosamine | 1 | 2009 | 14 | 0.070 |
Why?
| | Lipids | 2 | 2023 | 723 | 0.070 |
Why?
| | B-Lymphocytes | 1 | 2015 | 878 | 0.070 |
Why?
| | Models, Molecular | 2 | 2020 | 1606 | 0.070 |
Why?
| | Phenotype | 1 | 2017 | 3216 | 0.070 |
Why?
| | DNA Damage | 1 | 2022 | 440 | 0.070 |
Why?
| | Histone Acetyltransferases | 1 | 2019 | 57 | 0.070 |
Why?
| | Risk Factors | 1 | 2023 | 11017 | 0.070 |
Why?
| | Peptides | 1 | 2015 | 1003 | 0.070 |
Why?
| | Escherichia coli | 1 | 2003 | 836 | 0.070 |
Why?
| | Miller Fisher Syndrome | 1 | 2008 | 2 | 0.070 |
Why?
| | Mitochondrial Proteins | 1 | 2011 | 264 | 0.070 |
Why?
| | Guillain-Barre Syndrome | 1 | 2008 | 23 | 0.070 |
Why?
| | Benzamides | 1 | 2019 | 227 | 0.070 |
Why?
| | Multigene Family | 1 | 2009 | 210 | 0.070 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 947 | 0.070 |
Why?
| | Membrane Glycoproteins | 1 | 2011 | 499 | 0.070 |
Why?
| | Nitriles | 1 | 2019 | 211 | 0.070 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5476 | 0.070 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2007 | 16 | 0.070 |
Why?
| | DNA-Binding Proteins | 1 | 2015 | 1488 | 0.070 |
Why?
| | Cell Adhesion | 2 | 2020 | 451 | 0.060 |
Why?
| | Unfolded Protein Response | 1 | 2017 | 58 | 0.060 |
Why?
| | Pregnancy | 3 | 2023 | 7274 | 0.060 |
Why?
| | Molecular Weight | 1 | 2017 | 313 | 0.060 |
Why?
| | Membrane Proteins | 2 | 2020 | 1171 | 0.060 |
Why?
| | Multiple Myeloma | 1 | 2021 | 310 | 0.060 |
Why?
| | Hydrolysis | 1 | 2017 | 197 | 0.060 |
Why?
| | Protein Aggregates | 1 | 2017 | 86 | 0.060 |
Why?
| | Carrier Proteins | 1 | 2011 | 731 | 0.060 |
Why?
| | Protein Binding | 2 | 2017 | 2249 | 0.060 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2017 | 145 | 0.060 |
Why?
| | Butyrophilins | 1 | 2016 | 5 | 0.060 |
Why?
| | Glycine | 1 | 2007 | 186 | 0.060 |
Why?
| | Lipid Droplets | 1 | 2016 | 24 | 0.060 |
Why?
| | Critical Illness | 1 | 2013 | 907 | 0.060 |
Why?
| | Cross Reactions | 2 | 2008 | 130 | 0.060 |
Why?
| | Flow Cytometry | 3 | 2015 | 1172 | 0.060 |
Why?
| | Obesity | 1 | 2020 | 3149 | 0.060 |
Why?
| | Mammary Glands, Human | 1 | 2016 | 71 | 0.060 |
Why?
| | Cytoplasm | 1 | 2016 | 255 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2014 | 3448 | 0.060 |
Why?
| | Models, Chemical | 2 | 2006 | 251 | 0.050 |
Why?
| | Monocytes | 2 | 2023 | 539 | 0.050 |
Why?
| | Methylation | 2 | 2018 | 242 | 0.050 |
Why?
| | Lactation | 1 | 2016 | 195 | 0.050 |
Why?
| | Prospective Studies | 1 | 2017 | 8164 | 0.050 |
Why?
| | Chromosome Segregation | 2 | 2015 | 46 | 0.050 |
Why?
| | Aged | 4 | 2021 | 26514 | 0.050 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2016 | 196 | 0.050 |
Why?
| | 2,3-Diphosphoglycerate | 1 | 2023 | 32 | 0.050 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 17 | 0.050 |
Why?
| | Pelvic Floor | 1 | 2023 | 32 | 0.050 |
Why?
| | Kynurenine | 1 | 2024 | 114 | 0.050 |
Why?
| | Molecular Structure | 2 | 2009 | 488 | 0.050 |
Why?
| | Angiopoietins | 1 | 2022 | 12 | 0.050 |
Why?
| | Thymidine | 1 | 2022 | 60 | 0.050 |
Why?
| | Pancreatic Elastase | 1 | 2022 | 54 | 0.050 |
Why?
| | Parturition | 1 | 2023 | 73 | 0.050 |
Why?
| | Serine Proteinase Inhibitors | 1 | 2022 | 48 | 0.050 |
Why?
| | Brain | 1 | 2015 | 3009 | 0.050 |
Why?
| | Cohort Studies | 1 | 2023 | 6099 | 0.050 |
Why?
| | Random Allocation | 1 | 2023 | 366 | 0.050 |
Why?
| | Erythropoiesis | 1 | 2022 | 57 | 0.040 |
Why?
| | alpha-Globins | 1 | 2022 | 9 | 0.040 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2022 | 61 | 0.040 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 80 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2022 | 249 | 0.040 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 55 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2022 | 269 | 0.040 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 234 | 0.040 |
Why?
| | Mutation | 1 | 2022 | 4130 | 0.040 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 27 | 0.040 |
Why?
| | Membrane Microdomains | 1 | 2021 | 34 | 0.040 |
Why?
| | Least-Squares Analysis | 1 | 2021 | 73 | 0.040 |
Why?
| | Access to Information | 1 | 2021 | 48 | 0.040 |
Why?
| | Polymorphism, Genetic | 1 | 2023 | 615 | 0.040 |
Why?
| | Bacteriophage lambda | 1 | 2021 | 90 | 0.040 |
Why?
| | Fibrosis | 1 | 2023 | 568 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 172 | 0.040 |
Why?
| | Chromatin | 2 | 2015 | 561 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 590 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 114 | 0.040 |
Why?
| | Sulfhydryl Compounds | 1 | 2022 | 189 | 0.040 |
Why?
| | Phosphorylation | 2 | 2015 | 1721 | 0.040 |
Why?
| | Sperm Count | 1 | 2020 | 22 | 0.040 |
Why?
| | Heterozygote | 1 | 2021 | 317 | 0.040 |
Why?
| | Fatty Acids | 1 | 2023 | 461 | 0.040 |
Why?
| | Sperm Motility | 1 | 2020 | 37 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2021 | 195 | 0.040 |
Why?
| | Adolescent | 2 | 2020 | 22825 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2020 | 2054 | 0.040 |
Why?
| | Specimen Handling | 1 | 2021 | 183 | 0.040 |
Why?
| | Tissue Survival | 1 | 2018 | 16 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 512 | 0.040 |
Why?
| | Pepsin A | 1 | 2018 | 18 | 0.040 |
Why?
| | Blood Buffy Coat | 1 | 2018 | 6 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2022 | 481 | 0.040 |
Why?
| | Sulfates | 1 | 2018 | 45 | 0.040 |
Why?
| | Cell Communication | 1 | 2020 | 329 | 0.030 |
Why?
| | NF-kappa B | 1 | 2022 | 676 | 0.030 |
Why?
| | Glycosaminoglycans | 1 | 2018 | 79 | 0.030 |
Why?
| | Fluorescence | 1 | 2018 | 161 | 0.030 |
Why?
| | Filtration | 1 | 2018 | 68 | 0.030 |
Why?
| | Solutions | 1 | 2018 | 160 | 0.030 |
Why?
| | Bacteriological Techniques | 1 | 2018 | 66 | 0.030 |
Why?
| | Deamination | 1 | 2017 | 6 | 0.030 |
Why?
| | Complement Activation | 1 | 2021 | 401 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 556 | 0.030 |
Why?
| | DNA Methylation | 1 | 2022 | 722 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1197 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.030 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 593 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1496 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 29 | 0.030 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2006 | 97 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 97 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2020 | 646 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1672 | 0.030 |
Why?
| | Amides | 1 | 2006 | 101 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 630 | 0.030 |
Why?
| | Chromatids | 1 | 2015 | 10 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 327 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2890 | 0.030 |
Why?
| | HMGA2 Protein | 1 | 2015 | 10 | 0.030 |
Why?
| | Bromodeoxyuridine | 1 | 2015 | 77 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2015 | 43 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 132 | 0.030 |
Why?
| | Mice, Nude | 1 | 2017 | 680 | 0.030 |
Why?
| | Chromosomes | 1 | 2015 | 106 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 477 | 0.030 |
Why?
| | Electroporation | 1 | 2015 | 43 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2015 | 149 | 0.030 |
Why?
| | Carbohydrate Conformation | 1 | 2004 | 16 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2018 | 563 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 246 | 0.030 |
Why?
| | Immunoglobulin Light Chains | 1 | 2015 | 52 | 0.030 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2015 | 86 | 0.030 |
Why?
| | Serologic Tests | 1 | 2004 | 54 | 0.030 |
Why?
| | Seminal Plasma Proteins | 1 | 2014 | 11 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 930 | 0.030 |
Why?
| | Chromosomal Instability | 1 | 2014 | 21 | 0.030 |
Why?
| | Tranexamic Acid | 1 | 2015 | 63 | 0.030 |
Why?
| | Embryo Implantation | 1 | 2014 | 34 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 337 | 0.030 |
Why?
| | Fetal Stem Cells | 1 | 2013 | 8 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1772 | 0.020 |
Why?
| | Fertilization in Vitro | 1 | 2014 | 110 | 0.020 |
Why?
| | Species Specificity | 1 | 2004 | 547 | 0.020 |
Why?
| | Embryonic Development | 1 | 2014 | 125 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1049 | 0.020 |
Why?
| | DNA Repair | 1 | 2015 | 256 | 0.020 |
Why?
| | Microscopy, Atomic Force | 1 | 2013 | 129 | 0.020 |
Why?
| | Cell Count | 1 | 2013 | 321 | 0.020 |
Why?
| | Amino Acids | 1 | 2017 | 519 | 0.020 |
Why?
| | Immunoblotting | 1 | 2003 | 296 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 365 | 0.020 |
Why?
| | Oocyte Donation | 1 | 2012 | 6 | 0.020 |
Why?
| | Synovial Membrane | 1 | 2013 | 128 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2004 | 348 | 0.020 |
Why?
| | Cell Movement | 1 | 2017 | 966 | 0.020 |
Why?
| | Silver Staining | 1 | 2002 | 16 | 0.020 |
Why?
| | Disaccharides | 1 | 2002 | 21 | 0.020 |
Why?
| | Chronic Disease | 1 | 2018 | 1844 | 0.020 |
Why?
| | Wounds, Nonpenetrating | 1 | 2015 | 324 | 0.020 |
Why?
| | Wnt Signaling Pathway | 1 | 2013 | 212 | 0.020 |
Why?
| | Body Mass Index | 1 | 2020 | 2470 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2013 | 375 | 0.020 |
Why?
| | Cell Cycle | 1 | 2014 | 600 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1457 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 1127 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2496 | 0.020 |
Why?
| | Antibodies | 1 | 2002 | 398 | 0.020 |
Why?
| | Gene Order | 1 | 2009 | 29 | 0.020 |
Why?
| | Glycosyltransferases | 1 | 2009 | 16 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2009 | 69 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1875 | 0.020 |
Why?
| | Databases, Factual | 1 | 2015 | 1504 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 2009 | 152 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2008 | 24 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2008 | 18 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2009 | 122 | 0.020 |
Why?
| | Deoxyribonucleases | 1 | 2008 | 24 | 0.020 |
Why?
| | Cytokines | 1 | 2016 | 2086 | 0.020 |
Why?
| | Microwaves | 1 | 2008 | 29 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2008 | 320 | 0.020 |
Why?
| | Acylation | 1 | 2007 | 30 | 0.020 |
Why?
| | Child | 1 | 2023 | 22979 | 0.010 |
Why?
|
|
Headrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|